Inovio Pharmaceuticals, Inc. (INO)

NASDAQ: INO · Real-Time Price · USD

1.680

+0.050 (3.07%)

At close: Mar 17, 2026, 4:00 PM EDT

1.705

+0.025 (1.48%)

After-hours: Mar 17, 2026, 7:51 PM EDT

Inovio Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	44.27	65.81	14.31	46.33	71.14
Short-Term Investments	14.24	28.3	130.98	206.67	330.17
Cash & Short-Term Investments	58.51	94.11	145.29	253	401.31
Cash Growth	-37.83%	-35.23%	-42.57%	-36.96%	-2.51%
Accounts Receivable	-	-	2.41	11.74	8.03
Other Current Assets	2.61	3.72	5.41	50.51	39.1
Total Current Assets	61.12	97.83	153.11	315.24	448.44
Net Property, Plant & Equipment	9.07	11.77	14.45	17.96	29.02
Other Intangible Assets	-	-	-	2.13	2.63
Goodwill	-	-	-	10.51	10.51
Long-Term Investments	2.1	1.61	2.78	2.01	3.91
Other Long-Term Assets	2.01	1.98	0.61	0.68	1.43
Total Assets	74.31	113.2	170.95	348.53	495.94
Accounts Payable	11.13	17.55	20.92	80.91	48.19
Accrued Expenses	0.65	2.02	2.37	10.59	10.33
Current Portion of Long-Term Debt	-	-	16.77	-	-
Current Portion of Leases	2.82	2.5	2.41	2.8	2.6
Unearned Revenue	-	-	-	-	0.02
Other Current Liabilities	29.07	13.26	0.11	2.56	4.6
Total Current Liabilities	43.67	35.33	42.57	96.87	65.74
Long-Term Debt	-	-	-	16.61	14.96
Long-Term Leases	6.55	9.37	11.03	12.66	15.46
Other Long-Term Liabilities	-	-	-	0.03	0.11
Total Long-Term Liabilities	6.55	9.37	11.03	29.3	30.53
Total Liabilities	50.21	44.69	53.6	126.17	96.27
Common Stock	0.07	0.04	0.02	0.02	0.22
Additional Paid-in Capital	1,840	1,799	1,741	1,711	1,610
Accumulated Other Comprehensive Income	-0.64	-0.68	-0.66	-0.7	-0.28
Retained Earnings	-1,815	-1,730	-1,623	-1,488	-1,210
Shareholders' Equity	24.1	68.5	117.35	222.36	399.67
Total Liabilities & Equity	74.31	113.2	170.95	348.53	495.94
Total Debt	9.37	11.87	30.21	32.07	33.02
Net Cash (Debt)	49.14	82.25	115.08	220.92	368.29
Net Cash Growth	-40.25%	-28.53%	-47.91%	-40.01%	-1.16%
Net Cash Per Share	1.05	3.03	5.19	11.11	21.16
Book Value	24.1	68.5	117.35	222.36	399.67
Book Value Per Share	0.51	2.52	5.29	11.18	22.97
Tangible Book Value	24.1	68.5	117.35	209.72	386.53
Tangible Book Value Per Share	0.51	2.52	5.29	10.55	22.21

Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q